Medical Injection Molding Machine Market Report Scope & Overview:

The medical injection molding machine market size was valued at USD 2.10 billion in 2024 and is expected to reach USD 3.16 billion by 2032, growing at a CAGR of 5.24% over the forecast period of 2025-2032.

The medical injection molding machine market is experiencing substantial growth due to the surging healthcare needs and growing advancements in medical manufacturing technologies. From medical devices to diagnostic systems, pharmaceutical packaging, and surgical tools, these machines are crucial for creating accurate and high-quality parts. Manufacturers are heavily investing in advanced injection molding systems with particular emphasis on medical applications due to the high demand for both minimally invasive medical procedures and disposable medical items. Several major Medical Injection Molding Machine Market trends include a move toward automation and high-style cleanroom features to satisfy rigid, actuation-based precision engineering, along with qualified requirements. An equally critical trend is the use of safe, high-performance, and biocompatible materials in the crucial applications for ensuring reliability and safety. With the best use of Industry 4.0 technologies, including IoT and AI, live tracking and efficiency optimization are becoming really feasible.

In terms of Medical Injection Molding Machine Market growth, developing healthcare frameworks in developing nations and an increase in R&D exercises by key players in the field of clinical device development are driving real impetuses. Another key growth driver towards the adoption of better molding systems is the rising emphasis on sustainable and tailor-made production. The growing requirement for high-efficiency, compact size, and power-saving machines, is expected to steadily propel the market toward novel innovations and strategic collaborations from the major market players in the industry.

In June 2025, Fu Chun Shin (FCS) will debut its new CT-120e all-electric injection molding machine at the 2025 Taiwan Plastics, Rubber & Composite Material Fair. The CT-120e offers high-speed, precise molding with energy-efficient design and integrates with FCS’s smart manufacturing system. This launch highlights FCS’s focus on innovation for the medical, electronics, and optical industries.

Medical Injection Molding Machine Market Dynamics:

Drivers:

• Rising Demand for Medical Devices Driven by Chronic Diseases and Aging Population Spurs Growth in Advanced Injection Molding Solutions

The increasing global prevalence of chronic diseases and an aging population are significantly driving the demand for medical devices. The application of chronic diseases like diabetes, cardiovascular diseases, and respiratory disorders requires regular monitoring and management that drives the demand for prognostic instruments, monitoring units, and healing commissioning. At the same time, the golden-age demographic is more vulnerable to geriatric health problems, thus increasing the need for treatments. This increased demand highlights the need for efficient manufacturing processes including medical injection molding to create high-precision components that are critical for said medical devices. Injection molding processes are offering high-quality, low-cost medical components using advanced technologies and materials as the healthcare needs continue to rise.

In February 2025, GE HealthCare forecasted higher-than-expected profits for the year, driven by strong demand for its medical devices in the U.S. This growth is expected to offset weaker sales in China and the impact of new U.S. tariffs on Chinese products. The company’s imaging devices remain its largest revenue segment, supporting its positive outlook.

Restraints:

• High Capital Investment and Associated Operational Costs Create Significant Barriers for SMEs in the Medical Injection Molding Industry

Acquiring and maintaining advanced medical injection molding machines necessitates substantial capital investment, which acts as a major entry barrier for small and medium-sized enterprises (SMEs). The cost includes the machines as well as ancillary costs to support the machines, including cleanroom space, high-precision tooling, and automation systems. Injection molds can range from USD 10,000 to USD 100,000, depending on factors, such as tolerances needed, material choice, and production requirements.

For instance, injection molds tailor-made for medical devices commonly requires very tight tolerances and/or biocompatible materials. Also, maintaining and upgrading buildings come at a cost, and financial resources are quickly depleted. It can prevent smaller manufacturers from getting into the market or from growing their operations, thus suppressing competition against higher-capitalized companies.

Medical Injection Molding Machine Market Segmentation Analysis

By Product

The electric segment dominated the market and accounted for 48% of the Medical Injection Molding Machine Market share, due to their precision, energy efficiency, and suitability for cleanroom use. Every movement in these machines is driven by servo motors. Unlike hydraulic machines, the elimination of hydraulic oil in these machines reduces the chances of contamination, which is very critical in medical-grade manufacturing. This combination of higher repeatability and quicker cycle times is what gives them the advantage for mass production of small, delicate, and intricate medical components. Stringent regulations and an increasing demand for high-precision devices, such as syringes, diagnostic devices and surgical instruments introduced the domination of electric machines.

Hybrid injection molding machines, combining the strengths of hydraulic and electric systems, are the fastest-growing segment in the medical market. Compared to hydraulic machines, they provide better energy efficiency and accuracy while still delivering much higher forces. This makes them ideal for medium-sized medical parts where both speed and strength are required. Such machines are now being adopted more because of their flexibility, their lower operational cost with respect to a full electric machine, and their capacity to serve a wider range of applications. With medical device manufacturers looking for economical but high-efficiency solution, the hybrid segment is gaining rapid growth in the coming years.

By System

The Hot Runner system segment dominated the medical injection molding machine market in 2024, accounting for approximately 58% of the market share. This dominance can be associated with its high efficiency, less material waste, and high cycle times. Hot runner systems are always preferred in medical applications with higher precision and no tolerance on cleanliness since the injection temperature is maintained throughout the entire process, leading to better part quality. They are also perfect for high-volume fabrication, which is why they have become a primary solution for mass-producible medical items, such as syringes, diagnostic devices, and surgical tools.

Cold Runner systems are emerging as the fastest-growing segment in the medical injection molding machine market. They are expected to grow as they are cheaper to install with relatively lower maintenance costs than hot runner systems. These systems are especially beneficial for low volume production or when mold changeovers are frequent, both of which are a plus for SMEs entering the medical device space. Cold runner systems can be less economical and slower due to typically more scrap material and lower cycle times. However, as material recovery and mold design advance, cold runner systems are becoming more suitable in a broader range of cost-sensitive or specialized medical molding applications.

By Material

Plastics dominated the medical injection molding machine market by material in 2024, accounting for around 86% of the market share. Their versatility, biocompatibility, light weight, and cost-effectiveness lead to their predominance. Various types of plastics, such as polypropylene, polycarbonate, and polyethylene are commonly used in medical devices as they can be made sterile and as their complex geometries make them suitable for a wide range of uses. Additionally, the requirement for disposable medical items has increased after the pandemic, further supporting plastic injection molding. While regulatory standards remain focused on safety and hygiene, plastic is still the preferred material for the mass production of parts, such as catheters, IV connectors, and housing units.

Metals are the fastest-growing material segment in the medical injection molding machine market. Primarily, this growth is fueled by the increasing demand for biocompatible, durable, and high-strength medical parts, including orthopedic implants, surgical instruments, and dental appliances. Metal injection molding (MIM) is the marriage of plastic injection molding and metallurgical performance, whereby a manufacturer can make complex parts and outperform the competition. As MIM processes become cheaper and better, metal becomes a more viable and attractive choice for critical-use devices that require reliability and durability in extreme conditions.

Medical Injection Molding Machine Market Regional Outlook:

The Asia-Pacific dominates the global medical injection molding machine market with a 38% share in 2024 and is also the fastest-growing region. The growth is driven by rapid developments in the healthcare sector, surging medical devices demand, and large investments in manufacturing plants across China, India, Japan, and others. Government policies encouraging local manufacturing and the availability of low-cost, skilled personnel make the region a welcome base for the Group. Furthermore, growing health consciousness, increasing elderly population, and growing incidences of chronic diseases have been driving growth in the market for more sophisticated medical devices. The increasing manufacturing capability and export of medical parts within Asia-Pacific and the growing adoption of automation and other precision technologies also drive its studio growth.

China dominates the Asia-Pacific medical injection molding machine market due to its well-established manufacturing base, high technology penetration, and government assistance in the medical device industry. On the other hand, India serves as the fastest-growing market owing to increasing healthcare requirements,  incentives to manufacturing locally, and increasing foreign investments in medical manufacturing.

North America holds a significant share in the medical injection molding machine market, driven by its well-established healthcare infrastructure and consistent demand for high-quality, precision-engineered medical devices. It is characterized by the presence of several top manufacturers and suppliers that invest a lot in R&D and innovation in the region. The adoption of newer technology, particularly the electric and hybrid type molding machines, is encouraged by a strict regulatory framework exercised by agencies, such as the FDA, which ensures safety and quality at a very high standard. With advanced cleanroom manufacturing environments in combination with automation integration, the U.S. and Canada will continue to lead the way for medical technology innovations. North America may not be growing as rapidly as other regions. However, its focus on innovation and quality keeps it strong in the global market.

The U.S. medical injection molding machine market is expected to grow from USD 0.28 billion in 2024 to USD 0.41 billion by 2032, at a CAGR of 4.80%. Drivers of growth include increased precision medical component demand, innovative technology, and vigorous home production. The U.S. has the largest market share in North America on account of the flourishing healthcare and medical device sectors.

Key players in Medical Injection Molding Machine Market are:

Medical Injection Molding Machine Companies are Sumitomo (SHI) Demag Plastics Machinery GmbH, Husky Injection Molding Systems Ltd, Milacron MSA, Engel Machinery India Pvt. Ltd., Arburg GmbH + Co KG, The Japan Steel Works, Ltd., KraussMaffei Group, Toshiba Machine Co., Ltd., Wittmann Battenfeld, and UBE Machinery.

Recent Developments:

• In February 2025, Hillenbrand sold a majority 51% stake in its Milacron injection molding business to a Bain Capital affiliate for USD 287 million, retaining 49% ownership. The deal supports Hillenbrand’s shift toward higher-growth sectors like food and health. Proceeds will help reduce debt, and Bain’s investment aims to accelerate Milacron’s growth in engineered plastic processing.

• In March 2025, Husky Technologies expanded its presence in India by opening a new Delhi office and several support centers to boost sustainability efforts. These moves help manufacturers meet India's recycled plastic targets for 2026 and 2029. Husky also launched its Advantage+Enterprise platform to improve operational efficiency and product quality across factories.